Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using 1H and 31P magic angle spinning MRS of intact tissue

被引:27
作者
De Silva, Sonali S. [1 ,2 ]
Payne, Geoffrey S. [1 ,2 ]
Thomas, Valerie [3 ]
Carter, Paul G. [4 ]
Ind, Thomas E. J. [4 ]
deSouza, Nandita M. [1 ,2 ]
机构
[1] Inst Canc Res, Canc Res UK Clin Magnet Resonance Res Grp, Sutton SM2 5PT, Surrey, England
[2] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England
[3] St Georges Hosp NHS Trust, Dept Histopathol, London, England
[4] St Georges Hosp NHS Trust, Dept Obstet & Gynaecol, London, England
关键词
human; cervix; H-1; MRS; magic angle spinning; choline; CHOLINE PHOSPHOLIPID-METABOLISM; BREAST-CANCER; MALIGNANT-TRANSFORMATION; H-1-NMR SPECTROSCOPY; EX-VIVO; RESONANCE; C-13; TARGET; TUMORS; CELLS;
D O I
10.1002/nbm.1302
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The aim of this study was to determine the metabolic changes in the transition from pre-invasive to invasive cervical cancer using high-resolution magic angle spinning (HR-MAS) MRS. Biopsy specimens were obtained from women with histologically normal cervix (n = 5), cervical intraepithelial neoplasia (CIN; mild, n = 5; moderate/severe, n = 40), and invasive cancer (n = 23). H-1 HR-MAS MRS data were acquired using a Bruker Avance 11.74 T spectrometer (Carr-Purcell-Meiboom-Gill sequence; TR = 4.8 s; TE = 135 ms; 512 scans; 41 min acquisition). 31 P HR-MAS spectra were obtained from the normal subjects and cancer patients only (as acetic acid applied before tissue sampling in patients with CIN impaired spectral quality) using a H-1-decoupled pulse-acquire sequence (TR = 2.82 s; 2048 scans; 96 min acquisition). Peak assignments were based on values reported in the literature. Peak areas were measured using the AMARES algorithm. Estimated metabolite concentrations were compared between patient diagnostic categories and tissue histology using independent samples t tests. Comparisons based on patient category at diagnosis showed significantly higher estimated concentrations of choline (P = 0.0001) and phosphocholine (P = 0.002) in tissue from patients with cancer than from patients with high-grade dyskaryosis, but no differences between non-cancer groups. Division by histology of the sample also showed increases in choline (P = 0.002) and phosphocholine (P = 0.002) in cancer compared with high-grade CIN tissue. Phosphoethanolamine was increased in cancer compared with normal tissue (P = 0.0001). Estimated concentrations of alanine (P = 0.01) and creatine (P = 0.008) were significantly reduced in normal tissue from cancer patients compared with normal tissue from non-cancer patients. The estimated concentration of choline was significantly increased in CIN tissue from cancer patients compared with CIN tissue from non-cancer patients (P = 0.0001). Estimated concentrations of choline-containing metabolites increased from pre-invasive to invasive cervical cancer. Concurrent metabolite depletion occurs in normal tissue adjacent to cancer tissue. Copyright (C) 2008 John Wiley & Sons, Ltd.
引用
收藏
页码:191 / 198
页数:8
相关论文
共 38 条
[1]  
Aboagye EO, 1999, CANCER RES, V59, P80
[2]   Choline phospholipid metabolism: A target in cancer cells? [J].
Ackerstaff, E ;
Glunde, K ;
Bhujwalla, ZM .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (03) :525-533
[3]  
Ackerstaff E, 2001, CANCER RES, V61, P3599
[4]  
Armitage P., 2001, STAT METHODS MED RES, V4th
[5]  
Bhakoo KK, 1996, CANCER RES, V56, P4630
[6]   Non-destructive quantitation of spermine in human prostate tissue samples using HRMAS 1H NMR spectroscopy at 9.4 T [J].
Cheng, LL ;
Wu, CL ;
Smith, MR ;
Gonzalez, RG .
FEBS LETTERS, 2001, 494 (1-2) :112-116
[7]  
COMEL EB, 1993, J UROLOGY, V150, P2019
[8]   Observer accuracy in estimating proportions in images: implications for the semiquantitative assessment of staining reactions and a proposal for a new system [J].
Cross, SS .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (05) :385-390
[9]   Increased choline kinase activity in human breast carcinomas:: clinical evidence for a potential novel antitumor strategy [J].
de Molina, AR ;
Gutiérrez, R ;
Ramos, MA ;
Silva, JM ;
Silva, J ;
Bonilla, F ;
Sánchez, JJ ;
Lacal, JC .
ONCOGENE, 2002, 21 (27) :4317-4322
[10]   Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies [J].
Eliyahu, Galit ;
Kreizman, Tamar ;
Degani, Hadassa .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (08) :1721-1730